Comparison of Postoperative Delirium in Elders Anaesthetised With Midazolam and Without Midazolam

Sponsor
Chinese PLA General Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT05456230
Collaborator
Beijing Tiantan Hospital (Other), Peking University First Hospital (Other), The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School (Other), Xiangya Hospital of Central South University (Other), Beijing Anzhen Hospital (Other), China-Japan Friendship Hospital (Other), Fudan University (Other), Central South University (Other), Peking University People's Hospital (Other), Zhejiang University (Other), Sun Yat-sen University (Other), Wuhan Union Hospital, China (Other), Taihe Hospital (Other), The Affiliated Hospital Of Guizhou Medical University (Other), First Affiliated Hospital of Xinjiang Medical University (Other), First Affiliated Hospital of Guangxi Medical University (Other), Zhejiang Provincial People's Hospital (Other)
11,927
1
27.3
436.9

Study Details

Study Description

Brief Summary

This research project is an observational cohort study by prospective chart review of patients that underwent surgery in multi-centers, China, in the years 2020-2022. The purpose of this study is to compare the occurrence of postoperative delirium With Midazolam and Without Midazolam During Non-cardiac Surgery in Elders.

Condition or Disease Intervention/Treatment Phase

Detailed Description

Post operative delirium will be diagnosed using the 3D- CAM(Confusion Assessment Method) which tests for four features with a series of questions. The features include 1) acute onset and fluctuating course,2) inattention,3) disorganized thinking and 4) altered level of consciousness. Diagnosis of delirium is made if features 1 and 2 and either 3 or 4 are present.

The demographic data of the patients,type and site of surgery will be noted. Preoperative hemoglobin, serum electrolytes and blood urea will be recorded. The intraoperative factors like duration of surgery and anaesthesia,use of intravenous fluids ,blood loss, number blood units transfused and opioid use will be studied at the time of surgery. The time to emergence and extubation following the completion of surgery will be noted.

The postoperative factors like postoperative pain, nausea and vomiting, fever,hemoglobin,serum electrolytes and blood urea will be noted.

Preoperative and postoperative pain will be assessed using the numerical rating score on a scale of one to ten.

The association of various preoperative,intraoperative and postoperative factors with POD will be determined.

Study Design

Study Type:
Observational
Actual Enrollment :
11927 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Comparison of Postoperative Delirium in Elders Anaesthetised With Midazolam and Without Midazolam During Non-cardiac Surgery
Actual Study Start Date :
Apr 1, 2020
Actual Primary Completion Date :
Apr 30, 2022
Actual Study Completion Date :
Jul 11, 2022

Arms and Interventions

Arm Intervention/Treatment
Midazolam

Midazolam as a premedication was given as the patient is taken to the operating room and typically within 15 minutes of anesthetic induction.

Drug: Midazolam
Midazolam as a premedication was given as the patient is taken to the operating room and typically within 15 minutes of anesthetic induction.
Other Names:
  • benzodiazepines
  • Non-Midazolam

    Midazolam was not given during the operation.

    Outcome Measures

    Primary Outcome Measures

    1. Incidence of postoperative delirium [Day 1 postoperatively]

      Occurrence of delirium on any postoperative day, as assessed using the 3D-CAM or CAM-ICU daily

    2. Incidence of postoperative delirium [Day 2 postoperatively]

      Occurrence of delirium on any postoperative day, as assessed using the 3D-CAM or CAM-ICU daily

    3. Incidence of postoperative delirium [Day 3 postoperatively]

      Occurrence of delirium on any postoperative day, as assessed using the 3D-CAM or CAM-ICU daily

    4. Incidence of postoperative delirium [Day 4 postoperatively]

      Occurrence of delirium on any postoperative day, as assessed using the 3D-CAM or CAM-ICU daily

    5. Incidence of postoperative delirium [Day 5 postoperatively]

      Occurrence of delirium on any postoperative day, as assessed using the 3D-CAM or CAM-ICU daily

    6. Incidence of postoperative delirium [Day 7 postoperatively]

      Occurrence of delirium on any postoperative day, as assessed using the 3D-CAM or CAM-ICU daily

    Secondary Outcome Measures

    1. the incidence of survival rate [1 year]

      collection of clinical data in the medical record and follow-up update

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    65 Years and Older
    Sexes Eligible for Study:
    All
    Inclusion Criteria:

    Geriatric surgical patients ≥65 years old Underwent elective non-cardiac surgery

    Exclusion Criteria:

    History of neuropsychiatric diseases including delirium, mental disorders, Parkinson, dementia, etc.; The operation was cancelled due to various reasons after the patient was enrolled; severe liver disease; severe renal dysfunction defined as either having creatinine clearance < 30 ml/min or being dialysis-dependent; Patients who undergo second operation in a short period; Refused to participate in the study.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Chinese PLA General Hospital Beijing Beijing China 100853

    Sponsors and Collaborators

    • Chinese PLA General Hospital
    • Beijing Tiantan Hospital
    • Peking University First Hospital
    • The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
    • Xiangya Hospital of Central South University
    • Beijing Anzhen Hospital
    • China-Japan Friendship Hospital
    • Fudan University
    • Central South University
    • Peking University People's Hospital
    • Zhejiang University
    • Sun Yat-sen University
    • Wuhan Union Hospital, China
    • Taihe Hospital
    • The Affiliated Hospital Of Guizhou Medical University
    • First Affiliated Hospital of Xinjiang Medical University
    • First Affiliated Hospital of Guangxi Medical University
    • Zhejiang Provincial People's Hospital

    Investigators

    • Study Chair: Weidong Mi, PhD, Chinese PLA General Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Weidong Mi, Director (Cheif expert of National key research and development program of China 2018YFC2001900), Chinese PLA General Hospital
    ClinicalTrials.gov Identifier:
    NCT05456230
    Other Study ID Numbers:
    • PLAGH-POD-001
    First Posted:
    Jul 13, 2022
    Last Update Posted:
    Jul 18, 2022
    Last Verified:
    Jul 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jul 18, 2022